ICD-10-CM Billable Code

M61.09

Myositis ossificans traumatica, multiple sites

Clinical Classification Guidelines

Medical Intelligence & Overview

Myositis ossificans traumatica at multiple sites is a condition characterized by abnormal bone formation within muscle tissue following injury or trauma. This condition typically develops after repeated or severe muscular injuries, leading to calcification that resembles bone growth inside the soft tissues. Although it can occur in various parts of the body, it most commonly affects muscles in the arms, thighs, or hips. Recognizing the signs early and understanding the underlying causes can aid in managing the condition and preventing complications.

Causes & Symptoms

Clinical Causes: Traumatic injuries, such as fractures, crush injuries, or direct blows to the muscle Repeated muscle trauma or overuse, especially in athletes Surgical procedures involving muscles or bones Inconsistent or improper physical therapy after injury Genetic predisposition in certain cases, though uncommon

Key Symptoms: Localized swelling and palpable hard masses in the affected muscles Pain, especially during movement or pressure on the site Restricted range of motion in nearby joints Tenderness around the affected areas Possible visible deformity or abnormal contour in severe cases

Diagnostic & Treatment

Diagnosis Path: Physical examination to assess swelling, tenderness, and movement limitations X-rays to detect calcifications or ossification within soft tissues Ultrasound imaging to evaluate soft tissue changes Magnetic Resonance Imaging (MRI), especially when further detail on tissue involvement is needed Bone scans may sometimes be used to identify active ossification

Treatment Protocols: Rest and activity modification to limit muscle trauma Nonsteroidal anti-inflammatory drugs (NSAIDs) to manage pain and inflammation Physical therapy focusing on gentle stretching and strengthening exercises Cryotherapy or ice application to reduce swelling In some cases, surgical removal of the ossified tissue may be necessary, especially if it causes significant functional impairment or persistent pain Monitoring with regular imaging to assess progression and response to treatment

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M61.09 a billable ICD-10 code?
Yes, M61.09 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M61.09?
Clinical documentation must specify the nature of Myositis ossificans traumatica, multiple sites and any associated comorbidities for accurate reporting.

Cite this Clinical Reference